ES2180538T3 - Suministro dirigido de vector virico a celulas de mamiferos. - Google Patents
Suministro dirigido de vector virico a celulas de mamiferos.Info
- Publication number
- ES2180538T3 ES2180538T3 ES92922980T ES92922980T ES2180538T3 ES 2180538 T3 ES2180538 T3 ES 2180538T3 ES 92922980 T ES92922980 T ES 92922980T ES 92922980 T ES92922980 T ES 92922980T ES 2180538 T3 ES2180538 T3 ES 2180538T3
- Authority
- ES
- Spain
- Prior art keywords
- pct
- virus
- direct supply
- vector
- date
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/64—General methods for preparing the vector, for introducing it into the cell or for selecting the vector-containing host
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Biotechnology (AREA)
- Wood Science & Technology (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- General Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Microbiology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Plant Pathology (AREA)
- Animal Behavior & Ethology (AREA)
- Virology (AREA)
- Biochemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Cell Biology (AREA)
- Pulmonology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
SE DESCRIBE UN COMPLEJO ENTRE EL RECEPTOR DE ENLACE DE LA CELULA Y EL VIRUS QUE HA SIDO DESACTIVADO, Y UN ANTICUERPO, EL CUAL TIENE LA CAPACIDAD DE INTERACTUAR CON UN ANTIGENO ESPECIFICO SOBRE LA SUPERFICIE DE UNA CELULA DE MAMIFERO DISTINTA DE LA ESTRUCTURA CELULAR QUE DE OTRA MANERA INTERVIENE EN EL ENLACE DEL VIRUS CON LA SUPERFICIE DE LA CELULA, TENIENDO TAL ANTIGENO LA CAPACIDAD DE INTERVENIR EN LA ENTRADA DE UN VECTOR VIRUS O VIRUS INFECCIOSO DENTRO DE UNA CELULA DE MAMIFERO.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9103183A SE503225C2 (sv) | 1991-10-30 | 1991-10-30 | Virus-antikroppskomplex för införing av virus i mammalieceller |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2180538T3 true ES2180538T3 (es) | 2003-02-16 |
Family
ID=20384166
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES92922980T Expired - Lifetime ES2180538T3 (es) | 1991-10-30 | 1992-10-28 | Suministro dirigido de vector virico a celulas de mamiferos. |
Country Status (9)
Country | Link |
---|---|
US (1) | US5695991A (es) |
EP (1) | EP0614486B1 (es) |
JP (1) | JPH07502026A (es) |
AT (1) | ATE224442T1 (es) |
CA (1) | CA2122613C (es) |
DE (1) | DE69232782T2 (es) |
ES (1) | ES2180538T3 (es) |
SE (1) | SE503225C2 (es) |
WO (1) | WO1993009221A1 (es) |
Families Citing this family (37)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE503225C2 (sv) * | 1991-10-30 | 1996-04-22 | Leif Lindholm Konsult Ab | Virus-antikroppskomplex för införing av virus i mammalieceller |
GB9223084D0 (en) * | 1992-11-04 | 1992-12-16 | Imp Cancer Res Tech | Compounds to target cells |
DE4311651A1 (de) * | 1993-04-08 | 1994-10-13 | Boehringer Ingelheim Int | Virus für den Transport von Fremd-DNA in höhere eukaryotische Zellen |
US5846782A (en) * | 1995-11-28 | 1998-12-08 | Genvec, Inc. | Targeting adenovirus with use of constrained peptide motifs |
US6465253B1 (en) | 1994-09-08 | 2002-10-15 | Genvec, Inc. | Vectors and methods for gene transfer to cells |
US5753499A (en) * | 1994-12-23 | 1998-05-19 | New York University | Viral vector complexes having adapters of predefined valence |
US6127525A (en) * | 1995-02-21 | 2000-10-03 | Cornell Research Foundation, Inc. | Chimeric adenoviral coat protein and methods of using same |
US5770442A (en) | 1995-02-21 | 1998-06-23 | Cornell Research Foundation, Inc. | Chimeric adenoviral fiber protein and methods of using same |
US6261554B1 (en) | 1995-07-25 | 2001-07-17 | Introgene B.V. | Compositions for targeted gene delivery |
EA003195B1 (ru) * | 1995-11-13 | 2003-02-27 | Такара Сузо Ко., Лтд. | Способ повышения эффективности генного переноса в клетки-мишени с помощью ретровируса |
DE19605279A1 (de) | 1996-02-13 | 1997-08-14 | Hoechst Ag | Zielzellspezifische Vektoren für die Einschleusung von Genen in Zellen, Arzneimittel enthaltend derartige Vektoren und deren Verwendung |
CA2251738A1 (en) * | 1996-04-16 | 1997-10-23 | Immusol Incorporated | Targeted viral vectors |
US20060002949A1 (en) | 1996-11-14 | 2006-01-05 | Army Govt. Of The Usa, As Rep. By Secretary Of The Office Of The Command Judge Advocate, Hq Usamrmc. | Transcutaneous immunization without heterologous adjuvant |
US6797276B1 (en) | 1996-11-14 | 2004-09-28 | The United States Of America As Represented By The Secretary Of The Army | Use of penetration enhancers and barrier disruption agents to enhance the transcutaneous immune response |
DE19649645A1 (de) * | 1996-11-29 | 1998-06-04 | Hoechst Ag | Mehrfach funktionelles Ligandensystem zur zielzellspezifischen Übertragung von Nukleotidsequenzen |
US6432699B1 (en) | 1997-03-28 | 2002-08-13 | New York University | Viral vectors having chimeric envelope proteins containing the IgG-binding domain of protein A |
CA2285937C (en) | 1997-04-10 | 2010-12-14 | Frederick L. Hall | Modified proteins which bind extracellular matrix components |
AU7127798A (en) * | 1997-04-18 | 1998-11-13 | President And Fellows Of Harvard College | Bifunctional polypeptides for cell-specific viral targeting |
US6004798A (en) * | 1997-05-14 | 1999-12-21 | University Of Southern California | Retroviral envelopes having modified hypervariable polyproline regions |
CA2318981A1 (en) * | 1998-02-09 | 1999-08-12 | Genzyme Corporation | Nucleic acid delivery vehicles |
US6287857B1 (en) | 1998-02-09 | 2001-09-11 | Genzyme Corporation | Nucleic acid delivery vehicles |
US20060292121A1 (en) * | 1998-04-29 | 2006-12-28 | Hall Frederick L | Retroviral vectors including modified envelope escort protein |
US7078483B2 (en) | 1998-04-29 | 2006-07-18 | University Of Southern California | Retroviral vectors including modified envelope escort proteins |
AU4070499A (en) | 1998-04-30 | 1999-11-16 | Cornell Research Foundation Inc. | Adenoviral vectors with tandem fiber proteins |
US6060316A (en) * | 1998-06-09 | 2000-05-09 | President And Fellows Of Harvard College | Methods of targeting of viral entry |
US6455314B1 (en) | 1998-09-11 | 2002-09-24 | Genvec, Inc. | Alternatively targeted adenovirus |
AUPQ425699A0 (en) | 1999-11-25 | 1999-12-23 | University Of Newcastle Research Associates Limited, The | A method of treating a malignancy in a subject and a pharmaceutical composition for use in same |
JP2003534806A (ja) * | 2000-05-31 | 2003-11-25 | ジェンベク、インコーポレイティッド | アデノウイルスベクターのターゲティングの方法および組成物 |
AU2002953436A0 (en) | 2002-12-18 | 2003-01-09 | The University Of Newcastle Research Associates Limited | A method of treating a malignancy in a subject via direct picornaviral-mediated oncolysis |
US11266736B2 (en) | 2008-04-17 | 2022-03-08 | Vin De Bona Trading Company Pte Ltd | Method of painting micro vesicles |
EP2281033B1 (en) | 2008-04-17 | 2014-10-15 | Vin de Bona Trading Co Pte | Post release modification of viral envelopes |
CN110418650A (zh) | 2016-11-16 | 2019-11-05 | 免疫治疗有限公司 | 用于治疗过敏的核酸 |
EP3612556A1 (en) | 2017-04-22 | 2020-02-26 | Immunomic Therapeutics, Inc. | Improved lamp constructs |
US20200087365A1 (en) | 2017-05-02 | 2020-03-19 | Immunomic Therapeutics, Inc | Improved lamp constructs comprising cancer antigens |
US20210261647A1 (en) | 2018-05-15 | 2021-08-26 | Immunomic Therapeutics, Inc | Lamp constructs comprising allergens |
US20240108703A1 (en) | 2019-10-18 | 2024-04-04 | Immunomic Therapeutics, Inc. | Improved LAMP Constructs Comprising Cancer Antigens |
WO2023201201A1 (en) | 2022-04-10 | 2023-10-19 | Immunomic Therapeutics, Inc. | Bicistronic lamp constructs comprising immune response enhancing genes and methods of use thereof |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4364934A (en) * | 1979-12-04 | 1982-12-21 | Ortho Pharmaceutical Corporation | Monoclonal antibody to a human early thymocyte antigen and methods for preparing same |
US5428132A (en) * | 1987-10-11 | 1995-06-27 | United States Of America | Conjugate and method for integration of foreign DNA into cells |
JP2917998B2 (ja) * | 1988-02-05 | 1999-07-12 | ホワイトヘッド・インスティチュート・フォー・バイオメディカル・リサーチ | 修飾された肝細胞およびその用途 |
EP0466815A4 (en) * | 1989-04-05 | 1992-09-02 | Novacell Corpporation | Infectious targetted replication-defective virion |
FR2649119A1 (fr) * | 1989-06-30 | 1991-01-04 | Centre Nat Rech Scient | Procede de pilotage de retrovirus en utilisant des complexes bifonctionnels |
EP1001032A3 (en) * | 1989-08-18 | 2005-02-23 | Chiron Corporation | Recombinant retroviruses delivering vector constructs to target cells |
WO1991004753A1 (en) * | 1989-10-02 | 1991-04-18 | Cetus Corporation | Conjugates of antisense oligonucleotides and therapeutic uses thereof |
CA2092323A1 (en) * | 1990-10-01 | 1992-04-02 | George Y. Wu | Targeting viruses and cells for selective internalization by cells |
SE503225C2 (sv) * | 1991-10-30 | 1996-04-22 | Leif Lindholm Konsult Ab | Virus-antikroppskomplex för införing av virus i mammalieceller |
-
1991
- 1991-10-30 SE SE9103183A patent/SE503225C2/sv not_active IP Right Cessation
-
1992
- 1992-10-28 AT AT92922980T patent/ATE224442T1/de not_active IP Right Cessation
- 1992-10-28 US US08/232,028 patent/US5695991A/en not_active Expired - Fee Related
- 1992-10-28 CA CA002122613A patent/CA2122613C/en not_active Expired - Fee Related
- 1992-10-28 DE DE69232782T patent/DE69232782T2/de not_active Revoked
- 1992-10-28 EP EP92922980A patent/EP0614486B1/en not_active Revoked
- 1992-10-28 JP JP5508351A patent/JPH07502026A/ja not_active Ceased
- 1992-10-28 ES ES92922980T patent/ES2180538T3/es not_active Expired - Lifetime
- 1992-10-28 WO PCT/SE1992/000745 patent/WO1993009221A1/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
SE503225C2 (sv) | 1996-04-22 |
JPH07502026A (ja) | 1995-03-02 |
WO1993009221A1 (en) | 1993-05-13 |
DE69232782D1 (de) | 2002-10-24 |
SE9103183L (sv) | 1993-05-01 |
EP0614486B1 (en) | 2002-09-18 |
US5695991A (en) | 1997-12-09 |
SE9103183D0 (sv) | 1991-10-30 |
EP0614486A1 (en) | 1994-09-14 |
CA2122613C (en) | 2003-08-19 |
ATE224442T1 (de) | 2002-10-15 |
DE69232782T2 (de) | 2003-02-20 |
CA2122613A1 (en) | 1993-05-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2180538T3 (es) | Suministro dirigido de vector virico a celulas de mamiferos. | |
MY104946A (en) | Antigen antibody conjugate. | |
DE69126668D1 (de) | Mycobacterium als adjuvans für antigene | |
TR199701545T1 (xx) | Yeni dolastatin t�revleri,haz�rlanmalar� ve kullan�mlar� | |
DK0502979T3 (da) | Responselementpræparater og -assays for beta-retinsyre | |
NO883981L (no) | Fast katalysatorkomponent for olefinkopolymerisasjon og fremgangsmaate for olefinkopolymerisasjon ved anvendelse av nevnte faste katalysatorkomponent. | |
DE3777969D1 (de) | Brennstoffzellenrecyclingsystem. | |
FI932912A (fi) | Testmetod och reagensfoerpackning avsedd foer den | |
DE69021953T2 (de) | Enzymimmuntest für Antigene und dafür verwendbare feste Phase. | |
DE60017019D1 (de) | Antikörper gegen Spaltprodukte von Vimentin | |
DE3882727T2 (de) | Mycoplasma-Membran-Antigene und ihre Verwendung. | |
DK0547200T3 (da) | Rekombinante antistoffer på overfladen af E. coli | |
DE69130845T2 (de) | HLA-DR Antigen-Gen, dessen Nukleotidsequenz und Verwendung | |
PT553667E (pt) | Receptor do ldl soluvel sua producao e utilizacao | |
FR2681466B1 (fr) | Grappin orientable de manutention d'assemblage combustible nucleaire. | |
DK467888D0 (da) | Fremgangsmaade til fiksering af et antigen eller antistof samt et protein paa en baerer, saaledes overtrukket baerer og dens anvendelse. | |
FI922710A0 (fi) | Eliminering av aktiverade lymfocyter. | |
SE9102014D0 (sv) | Foerfarande i samband med mammalieceller | |
EP0342422A3 (en) | Process for the preparation of 2',3'-dideoxynucleosides, and intermediates used therein | |
DE29705307U1 (de) | Mehrzweck-Trägergerät | |
PT650523E (pt) | Antigene cdw52 recombinante | |
IT1262976B (it) | Oligonucleotidi antisenso e loro uso | |
HOJO | Intensive Report from Respective Parts of Research on “Buddhism and Anthropology” | |
IT9006602A0 (it) | Test immunoenzimatico per la ricerca e determinazione degli anticorpi anti-ss-dna. | |
IT220437Z2 (it) | Raccoglitore con caratteristiche ecologiche, per fogli e simili |